@msk_radonc : This review discusses cisplatin ineligibility in pts with locally advanced #HNC #hncsm, summarizes the limited clinical evidence for adjuvant tx, & highlights ongoing clinical trials that have the potential to provide new tx options. sciencedirect.com/science/articl… • TwiCopy

Memorial Sloan Kettering Radiation Oncology

@msk_radonc

+ Follow

The official account of the Radiation Oncology Department at Memorial Sloan Kettering Cancer Center @MSKCancerCenter #radonc

ID: 1164226031273893890

linkhttps://www.mskcc.org/departments/radiation-oncology calendar_today21-08-2019 17:21:50

1,1K Tweet

4,4K Followers

373 Following

Memorial Sloan Kettering Radiation Oncology

@msk_radonc

a year ago

This review discusses cisplatin ineligibility in pts with locally advanced #HNC #hncsm, summarizes the limited clinical evidence for adjuvant tx, & highlights ongoing clinical trials that have the potential to provide new tx options. sciencedirect.com/science/articl…